One large 2024 study in the journal Scientific Reports found that people with obesity who were taking GLP-1s had a slightly elevated risk of anxiety and suicidal behavior when compared to a control group, and almost double the risk of major depression
Research is showing that women are driving much of that demand related to weight loss supportin fact, an August 2025 RAND report found that nearly one in five women ages 50 to 64 now take a GLP-1, with overall usage higher among women than men
Confirm the prescribed dose on the pen before every injection
Drink pure or diluted in a glass of water
By selectively inhibiting NNMT , 5-Amino-1MQ can reduce the methylation of nicotinamide, leading to increased intracellular NAD availability and enhanced metabolic activity
Lets take a closer look at some of the important changes in 2025: Also, theres a sharper focus on prior authorization compliance